| OPPOSITION | - Adler Amanda, Ray Armstrong, Jeff Aronson, Peter Barry, Michael Boscoe, John Cairns, Mark Chakravarty, Fergus Gleeson, Sally Gooch, Eleanor Grey, Sanjay Gupta, Neil Iosson, Terence Lewis, Ruairidh Milne, Stephen Palmer, John Pounsford, Navin Sewak, Lindsay Smith, Roderick Smith, Cliff Snelling, Ken Stein, Andrew Stevens, Rod Taylor, Tom Wilson, Whitney Miller, Zoe Garrett, Jeremy Powell, "Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor ", Technology appraisal guidance TA195, NICE - National Institute for Health and Care Excellence, (20100825), pages 1 - 72, Technology appraisal guidance TA195, URL: https://www.nice.org.uk/guidance/ta195/resources/adalimumab-etanercept-infliximab-rituximab-and-abatacept-for-the-treatment-of-rheumatoid-arthritis-after-the-failure-of-a-tnf-inhibitor-pdf-82598558287813, (20240222), XP093134108 | - |
| OPPOSITION | - Anonymous, "Induce Definition & Meaning", Merriam-Webster Dictionary, Merriam-Webster, (20240429), pages 1 - 3, Merriam-Webster Dictionary, URL: https://www.merriam-webster.com/dictionary/induce, XP093156873 | - |
| OPPOSITION | - Anonymous, "ORENCIA 250 mg powder for concentrate for solution for infusion", Medicines, (20210719), pages 1 - 20, Medicines, URL: https://www.medicines.org.uk/emc/product/334/smpc/print, (20240926), XP093230903 | - |
| OPPOSITION | - Anonymous, " Orencia (abatacept): An overview of Orencia and why it is authorised in the EU", Orencia abatacept - Overview, European Medicines Agency, (20190412), pages 1 - 4, Orencia abatacept - Overview, URL: https://www.ema.europa.eu/en/documents/overview/orencia-epar-medicine-overview_en.pdf, (20240222), XP093134084 | - |
| OPPOSITION | - Anonymous, "Rituximab", Wikipedia, (20240107), pages 1 - 14, Wikipedia, URL: https://en.wikipedia.org/w/index.php?title=Rituximab&oldid=1194117095, XP093156887 | - |
| OPPOSITION | - Anonymous, "Trial of Orencia in Patients With Myasthenia Gravis ", Clinical trial (NCT03059888), (20170223), pages 1 - 11, Clinical trial (NCT03059888), URL: https://clinicaltrials.gov/study/NCT03059888, (20240925), XP093208674 | - |
| OPPOSITION | - Bristol-Myers Squibb, "NCT01714817 | Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis", ClinicalTrials.gov, NLM, (20180730), pages 1 - 102, ClinicalTrials.gov, URL: https://clinicaltrials.gov/study/NCT01714817?tab=history&a=86, (20240222), XP093134078 | - |
| OPPOSITION | - Bristol-Myers Squibb, "NCT01714817 | Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis", ClinicalTrials.gov, NLM, (20210224), pages 1 - 94, ClinicalTrials.gov, URL: https://clinicaltrials.gov/study/NCT01714817?tab=history&a=88, (20240222), XP093134072 | - |
| OPPOSITION | - Columbia University, "NCT03619876 | Effects of Abatacept on Myocarditis in Rheumatoid Arthritis (AMiRA)", ClinicalTrials.gov, NLM, (20180813), pages 1 - 15, ClinicalTrials.gov, URL: https://clinicaltrials.gov/study/NCT03619876?tab=history&a=2, (20240222), XP093134088 | - |
| OPPOSITION | - Czaja, A.J. ; Manns, M.P., "Advances in the Diagnosis, Pathogenesis, and Management of Autoimmune Hepatitis", Gastroenterology, Elsevier Inc., US, US , (20100701), vol. 139, no. 1, ISSN 0016-5085, pages 58 - 72.e4, XP027202913 | - |
| OPPOSITION | - Francis J Dumont, "Technology evaluation: Abatacept, Bristol-Myers Squibb", CURRENT OPINION IN MOLECULAR THERAPEUTICS, CURRENT DRUGS, London, GB, London, GB , (20040101), vol. 6, no. 3, ISSN 1464-8431, pages 318 - 330, XP009552258 | - |
| OPPOSITION | - George Washington University, "NCT02594735 | Abatacept in Juvenile Dermatomyositis (AID)", ClinicalTrials.gov, NLM, (20190124), pages 1 - 22, ClinicalTrials.gov, URL: https://clinicaltrials.gov/study/NCT02594735?tab=history&a=9, (20240222), XP093134093 | - |
| OPPOSITION | - Millar Liesl, Helen Powell, Ian Watson, Christian Griffiths, Sally Doss, Kate Moore , "Immunosuppressive therapy for kidney transplant in adults", Technology appraisal guidance TA481, NICE - National Institute for Health and Care Excellence, ISBN 978-1-4731-1702-0, (20171011), pages 1 - 43, Technology appraisal guidance TA481, URL: https://www.nice.org.uk/guidance/ta481/resources/immunosuppressive-therapy-for-kidney-transplant-in-adults-pdf-82605021450181, (20240222), XP093134096 | - |
| OPPOSITION | - Rohit Aggarwal, "NCT03215927 | Abatacept for the Treatment of Myositis-associated Interstitial Lung Disease (ATtackMy-ILD)", ClinicalTrials.gov, NLM, (20171009), pages 1 - 19, ClinicalTrials.gov, URL: https://clinicaltrials.gov/study/NCT03215927?tab=history&a=5, (20240222), XP093134090 | - |
| OPPOSITION | - RANHEIM E A, KIPPS T J, "Elevated expression of CD80 (B7/BB1) and other accessory molecules on synovial fluid mononuclear cell subsets in rheumatoid arthritis", Arthritis & Rheumatism, Wiley InterScience, US, US , (19941101), vol. 37, no. 11, doi:10.1002/art.1780371113, ISSN 0004-3591, pages 1637 - 1646, XP003016047 | |
| OPPOSITION | - "Treatment of Lupus Nephritis With Abatacept: The Abatacept and Cyclophosphamide Combination Efficacy and Safety Study", Arthritis & Rheumatology, John Wiley & Sons, Inc., US, US , (20141026), vol. 66, no. 11, doi:10.1002/art.38790, ISSN 2326-5191, pages 3096 - 3104, XP072277591 | |
| OPPOSITION | - Carol A. Langford; David Cuthbertson; Steven R. Ytterberg; Nader Khalidi; Paul A. Monach; Simon Carette; Philip Seo; Larry W. Moreland; Michael Weisman; Curry L. Koening; Antoine G. Sreih; Robert Spiera; Carol A. McAlear; Kenneth J. Warrington; Christian Pagnoux; Kathleen McKinnon; Lindsy J. Forbess; Gary S. Hoffman; Renée Borchin; Jeffrey P. Krischer; Peter A. Merkel, "A Randomized, Double‐Blind Trial of Abatacept (CTLA‐4Ig) for the Treatment of Giant Cell Arteritis", Arthritis & Rheumatology, John Wiley & Sons, Inc., US, US , (20170303), vol. 69, no. 4, doi:10.1002/art.40044, ISSN 2326-5191, pages 837 - 845, XP072274527 | |
| OPPOSITION | - Kerola Anne M.; Kauppi Markku J., "Abatacept as a successful therapy for myositis—a case-based re", Clinical Rheumatology, ACTA MEDICA BELGICA, BRUXELLES., BE, BE , (20140204), vol. 34, no. 3, doi:10.1007/s10067-014-2507-4, ISSN 0770-3198, pages 609 - 612, XP035461016 | |
| OPPOSITION | - Abe, S. Hanawa, H. Hayashi, M. Yoshida, T. Komura, S. Watanabe, R. Lie, H. Chang, H. Kato, K. Kodama, M. Maruyama, H. Nakazawa, M. Miyazaki, J. Aizawa, Y., "Prevention of Experimental Autoimmune Myocarditis by Hydrodynamics-Based Naked Plasmid DNA Encoding CTLA4-Ig Gene Delivery", JOURNAL OF CARDIAL FAILURE., CHURCHILL LIVINGSTONE, NAPERVILLE, IL., US, US , (20050901), vol. 11, no. 7, doi:10.1016/j.cardfail.2005.04.005, ISSN 1071-9164, pages 557 - 564, XP005087598 | |
| OPPOSITION | - Han et al., "CTLA4-Ig Relieves Inflammation in Murine Models of Coxsackievirus B3-Induced Myocarditis", Canadian Journal of Cardiology, (2012), vol. 28, doi:10.1016/j.cjca.2011.11.014, XP055270282 | |
| OPPOSITION | - Michot J.M.; Bigenwald C.; Champiat S.; Collins M.; Carbonnel F.; Postel-Vinay S.; Berdelou A.; Varga A.; Bahleda R.; Hollebecque A.; Massard C.; Fuerea A.; Ribrag V.; Gazzah A.; Armand J.P.; Amellal N.; Angevin E.; Noel N.; Boutros C.; Mateus C.; Robert C.; Soria J.C.; Marabelle A.; Lambotte O., "Immune-related adverse events with immune checkpoint blockade: a comprehensive review", European Journal of Cancer, Elsevier, 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, Barcelona, Spain, 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, Barcelona, Spain, (20160105), vol. 54, doi:10.1016/j.ejca.2015.11.016, ISSN 0959-8049, pages 139 - 148, XP029401839 | |
| OPPOSITION | - Michel Lars, Rassaf Tienush, Totzeck Matthias, "Cardiotoxicity from immune checkpoint inhibitors", IJC Heart & Vasculature, (20191201), vol. 25, doi:10.1016/j.ijcha.2019.100420, ISSN 2352-9067, pages 100420 - 7, XP093133956 | |
| OPPOSITION | - Itzhaki Ben Zadok Osnat, Ben-Avraham Ben, Nohria Anju, Orvin Katia, Nassar Mithal, Iakobishvili Zaza, Neiman Victoria, Goldvaser Hadar, Kornowski Ran, Ben Gal Tuvia, "Immune-Checkpoint Inhibitor-Induced Fulminant Myocarditis and Cardiogenic Shock", JACC: CardioOncology, Elsevier, (20190901), vol. 1, no. 1, doi:10.1016/j.jaccao.2019.07.004, ISSN 2666-0873, pages 141 - 144, XP093133951 | |
| OPPOSITION | - Lee Sangmoon; Moon Jin Soo; Lee Cho-Rong; Kim Hye-Eun; Baek Sun-Mi; Hwang Solha; Kang Gyeong Hoon; Seo Jeong Kee; Shin Choong Ho; Kang Hyoung Jin; Ko Jae Sung; Park Sung Gyoo; Choi Murim, "Abatacept alleviates severe autoimmune symptoms in a patient carrying ade novovariant inCTLA-4", Journal of Allergy and Clinical Immunology, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20151021), vol. 137, no. 1, doi:10.1016/j.jaci.2015.08.036, ISSN 0091-6749, pages 327 - 330, XP029379377 | |
| OPPOSITION | - Dantzer Jennifer A.; Lederman Howard M.; Cuffari Carmelo, "An 18 year old with CTLA-4 mutation with Severe Enteropathy and Respiratory Disease Treated with Anti-Thymocyte Globulin, Abatacept, and Sirolimus", Journal of Allergy and Clinical Immunology, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (19000101), vol. 139, no. 2, doi:10.1016/j.jaci.2016.12.345, ISSN 0091-6749, XP029936416 | |
| OPPOSITION | - Arabshahi Bita, Silverman Robert A., Jones Olcay Y., Rider Lisa G., "Abatacept and Sodium Thiosulfate for Treatment of Recalcitrant Juvenile Dermatomyositis Complicated by Ulceration and Calcinosis", JOURNAL OF PEDIATRICS., MOSBY-YEAR BOOK, ST. LOUIS, MO, US, US , (20120301), vol. 160, no. 3, doi:10.1016/j.jpeds.2011.11.057, ISSN 0022-3476, pages 520 - 522, XP093133993 | |
| OPPOSITION | - Salem Joe-Elie, Manouchehri Ali, Moey Melissa, Lebrun-Vignes Bénédicte, Bastarache Lisa, Pariente Antoine, Gobert Aurélien, Spano Jean-Philippe, Balko Justin M, Bonaca Marc P, Roden Dan M, Johnson Douglas B, Moslehi Javid J, "Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study", The Lancet Oncology, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL, (20181201), vol. 19, no. 12, doi:10.1016/S1470-2045(18)30608-9, ISSN 1470-2045, pages 1579 - 1589, XP093133998 | |
| OPPOSITION | - Michael Conroy, "Immune-related adverse events and the balancing act of immunotherapy", Nature Communications, Nature Publishing Group, UK, UK, (20220119), vol. 13, no. 1, doi:10.1038/s41467-022-27960-2, ISSN 2041-1723, pages 392 - 4, XP093156879 | |
| OPPOSITION | - William J. Sandborn; Jean Frederic Colombel; Bruce E. Sands; Paul Rutgeerts; Stephan R. Targan; Remo Panaccione; Brian Bressler; Karl Geboes; Stefan Schreiber; Richard Aranda; Sheila Gujrathi; Allison Luo; Yun Peng; Luisa Salter Cid; Stephen B. Hanauer;, "Abatacept for Crohn's Disease and Ulcerative Colitis", Gastroenterology, Elsevier Inc., US, US , (20120406), vol. 143, no. 1, doi:10.1053/j.gastro.2012.04.010, ISSN 0016-5085, pages 62 - 69.e4, XP028497400 | |
| OPPOSITION | - Kumar Bharat, Zuhair Ballas, "Adverse Events Associated with Immune Checkpoint Blockade", The New England journal of medicine, Massachusetts Medical Society, US, US , (20180322), vol. 378, no. 12, doi:10.1056/NEJMc1801663, ISSN 0028-4793, pages 1163 - 1165, XP093133944 | |
| OPPOSITION | - Joe-Elie Salem, Yves Allenbach, Aurore Vozy, Nicolas Brechot, Douglas B. Johnson, Javid J. Moslehi, Mathieu Kerneis, "Abatacept for Severe Immune Checkpoint Inhibitor-Associated Myocarditis", The New England journal of medicine, Massachusetts Medical Society, US, US , (20190613), vol. 380, no. 24, doi:10.1056/NEJMc1901677, ISSN 0028-4793, pages 2377 - 2379, XP055854888 | |
| OPPOSITION | - Genovese et al., "Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor a Inhibition", The New England Journal of Medicine, (2005), vol. 353, doi:10.1056/NEJMoa050524, XP055087310 | |
| OPPOSITION | - Postow Michael A., Sidlow Robert, Hellmann Matthew D., "Immune-Related Adverse Events Associated with Immune Checkpoint Blockade", The New England journal of medicine, Massachusetts Medical Society, US, US , (20180111), vol. 378, no. 2, doi:10.1056/NEJMra1703481, ISSN 0028-4793, pages 158 - 168, XP093116380 | |
| OPPOSITION | - Wei Liu, Wei-Min Li, Cheng Gao, Bao-Guo Zhou, "Upregulation of CD4 + CD25 + T lymphocyte by adenovirus-mediated gene transfer of CTLA4Ig fusion protein in experimental autoimmune myocarditis", AUTOIMMUNITY, Informa Healthcare, GB, GB , (20060101), vol. 39, no. 4, doi:10.1080/08916930600758035, ISSN 0891-6934, pages 289 - 298, XP009552261 | |
| OPPOSITION | - Hu Jiun-Ruey, Florido Roberta, Lipson Evan J, Naidoo Jarushka, Ardehali Reza, Tocchetti Carlo G, Lyon Alexander R, Padera Robert F, Johnson Douglas B, Moslehi Javid, "Cardiovascular toxicities associated with immune checkpoint inhibitors", Cardiovascular Research, Oxford University Press, GB, GB , (20190415), vol. 115, no. 5, doi:10.1093/cvr/cvz026, ISSN 0008-6363, pages 854 - 868, XP093116381 | |
| OPPOSITION | - Hu Jiun-Ruey, Florido Roberta, Lipson Evan J, Naidoo Jarushka, Ardehali Reza, Tocchetti Carlo G, Padera Robert, Johnson Douglas B, Moslehi Javid, Cardio-Oncology, Program, "Cardiovascular Toxicities Associated with Immune Checkpoint Inhibitors", CVR-2018-1323 Immune Checkpoint Inhibitor Cardiovascular Toxicity, (20190213), doi:10.1093/cvr/cvz026/5304411, pages 1 - 52, XP093116382 | |
| OPPOSITION | - Belkhir Rakiba, Burel Sébastien Le, Dunogeant Laetitia, Marabelle Aurélien, Hollebecque Antoine, Besse Benjamin, Leary Alexandra, Voisin Anne-Laure, Pontoizeau Clémence, Coutte Laetitia, Pertuiset Edouard, Mouterde Gaël, Fain Olivier, Lambotte Olivier, Mariette Xavier, "Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment", Annals of the Rheumatic Diseases, BMJ Publ. Group, GB, GB, (20171001), vol. 76, no. 10, doi:10.1136/annrheumdis-2017-211216, ISSN 0003-4967, pages 1747 - 1750, XP009552268 | |
| OPPOSITION | - Tjärnlund Anna, Tang Quan, Wick Cecilia, Dastmalchi Maryam, Mann Herman, Tomasová Studýnková Jana, Chura Radka, Gullick Nicola J, Salerno Rosaria, Rönnelid Johan, Alexanderson Helene, Lindroos Eva, Aggarwal Rohit, Gordon Patrick, Vencovsky Jiri, Lundberg Ingrid E, "Abatacept in the treatment of adult dermatomyositis and polymyositis: a randomised, phase IIb treatment delayed-start trial", Annals of the Rheumatic Diseases, BMJ Publ. Group, GB, GB, (20180101), vol. 77, no. 1, doi:10.1136/annrheumdis-2017-211751, ISSN 0003-4967, pages 55 - 62, XP009552259 | |
| OPPOSITION | - Salem Joe-Elie, Bretagne Marie, Abbar Baptiste, Leonard-Louis Sarah, Ederhy Stéphane, Redheuil Alban, Boussouar Samia, Nguyen Lee S., Procureur Adrien, Stein Frederic, Fenioux Charlotte, Devos Perrine, Gougis Paul, Dres Martin, Demoule Alexandre, Psimaras Dimitri, Lenglet Timothee, Maisonobe Thierry, De Chambrun Marc Pineton, Hekimian Guillaume, Straus Christian, Gonzalez-Bermejo Jesus, Klatzmann David, Rigolet Aude, Guillaume-Jugnot Perrine, Champtiaux Nicolas, Benveniste Olivier, Weiss Nicolas, Saheb Samir, Rouvier Philippe, Plu Isabelle, Gandjbakhch Estelle, Kerneis Mathieu, Hammoudi Nadjib, Zahr Noel, Llontop Claudia, Morelot-Panzini Capucine, Lehmann Lorenz, Qin Juan, Moslehi Javid J., Rosenzwajg Michelle, Similowski Thomas, Allenbach Yves, "Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis", Cancer discovery, US , (20230504), vol. 13, no. 5, doi:10.1158/2159-8290.CD-22-1180, ISSN 2159-8274, pages 1100 - 1115, XP093193327 | |
| OPPOSITION | - Uzel Gulbu; Karanovic Djuro; Su Hua; Rump Amy; Agharahimi Anahita; Holland Steven M.; Rao V. Koneti, "Management of Cytopenias in CTLA4 Haploinsufficiency Using Abatacept and Sirolimus", Blood, American Society of Hematology, US, US , (20181129), vol. 132, doi:10.1182/blood-2018-99-120185, ISSN 0006-4971, page 2409, XP086594668 | |
| OPPOSITION | - Kennedy Lucy Boyce, Salama April K. S., "A review of cancer immunotherapy toxicity", CA., AMERICAN CANCER SOCIETY., NEW YORK, NY., US, US , (20200301), vol. 70, no. 2, doi:10.3322/caac.21596, ISSN 0007-9235, pages 86 - 104, XP093134060 | |
| OPPOSITION | - Kumar Dhiren, Lecorchick Spencer, Gupta Gaurav, "Belatacept As an Alternative to Calcineurin Inhibitors in Patients with Solid Organ Transplants", Frontiers in Medicine, vol. 4, doi:10.3389/fmed.2017.00060, page 60, XP093073094 | |
| OPPOSITION | - Takahashi Nobunori, Kojima Toshihisa, Kaneko Atsushi, Kida Daihei, Hirano Yuji, Fujibayashi Takayoshi, Yabe Yuichiro, Takagi Hideki, Oguchi Takeshi, Miyake Hiroyuki, Kato Takefumi, Watanabe Tsuyoshi, Hayashi Masatoshi, Kanayama Yasuhide, Funahashi Koji, Asai Shuji, Yoshioka Yutaka, Takemoto Toki, Terabe Kenya, Asai Nobuyuki, Ishiguro Naoki, "Longterm Efficacy and Safety of Abatacept in Patients with Rheumatoid Arthritis Treated in Routine Clinical Practice: Effect of Concomitant Methotrexate after 24 Weeks", JOURNAL OF RHEUMATOLOGY, Journal of Rheumatology Publishing Company., CA, CA , (20150501), vol. 42, no. 5, doi:10.3899/jrheum.141288, ISSN 0315-162X, pages 786 - 793, XP093133988 | |
| OPPOSITION | - Israël-Assayag Evelyne, Fournier Marcien, Cormier Yvon, "Blockade of T Cell Costimulation by CTLA4-Ig Inhibits Lung Inflammation in Murine Hypersensitivity Pneumonitis", The Journal of Immunology, Williams & Wilkins Co., US , (19991215), vol. 163, no. 12, doi:10.4049/jimmunol.163.12.6794, ISSN 0022-1767, pages 6794 - 6799, XP093131046 | |
| OPPOSITION | - Anroopb Nair, Shery Jacob, "A simple practice guide for dose conversion between animals and human", Journal of Basic and Clinical Pharmacy, India , (20160501), vol. 7, no. 2, doi:10.4103/0976-0105.177703, ISSN 0976-0105, page 27, XP055627116 | |
